Polygenic Risk Score May Identify Patients at High Risk of Nasopharyngeal Carcinoma
The risk score can improve upon EBV-based screening, according to researchers.
Nasopharyngeal Cancer
Adding Tislelizumab to Chemo Slows Advanced Nasopharyngeal Cancer
Progression-free survival prolonged with tislelizumab + chemotherapy versus chemotherapy alone in recurrent/metastatic NPC.
Systematic Nutrition Management for Locally Advanced Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy
[OncoTargets and Therapy] The aim of this study was to evaluate the impact of SNM on nutritional status, treatment-related toxicity, QoL, response rates, and survival in LA-NPC patients treated by RT.
Evolutionary Role of Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Literature-based Network Meta-analysis
[Cancer Management and Research] This network meta-analysis seeks to establish the optimal treatment in advanced nasopharyngeal carcinoma (NPC).
Uric Acid May Mark Progression for Nasopharyngeal Cancer
High pretreatment uric acid may be a clinical biomarker for lung metastasis.
Gemcitabine Plus Cisplatin Prolongs PFS in Nasopharyngeal Cancer
Gemcitabine in combination with cisplatin is associated with a significant improvement in progression-free survival in nasopharyngeal carcinoma.
Link between nasal allergies increased risk of nasopharyngeal cancer
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma (NPC), according to a study.
Allergic rhinitis associated with increased risk of nasopharyngeal cancer
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
Genetic map created of nasopharyngeal cancer
A team of scientists from Singapore has identified a distinct mutational signature and nine mutated genes associated with nasopharyngeal cancer.
Study finds potential avenues for nasopharyngeal cancer treatment
A team of scientists have discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing targeted therapies.
- Loading...
Loading...
Loading... 
Loading...